Ryman Healthcare Limited

Equities

RYM

NZRYME0001S4

Healthcare Facilities & Services

End-of-day quote New Zealand S.E. 06:00:00 2024-07-11 pm EDT 5-day change 1st Jan Change
4.12 NZD +7.01% Intraday chart for Ryman Healthcare Limited +20.47% -30.17%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
New Zealand Shares Jump on Positive Central Bank Outlook MT
Ryman Healthcare Chooses PwC Auckland as External Auditor MT
Transcript : Ryman Healthcare Limited, 2024 Earnings Call, May 27, 2024
Ryman Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Jarden Upgrades Ryman Healthcare to Neutral from Underweight, Price Target is NZ$4.36 MT
New Zealand Shares Jumps on Business Optimism; Ryman Healthcare CEO Resigns MT
Ryman Healthcare Group CEO Resigns MT
Ryman Healthcare Lowers Fiscal Year 2024 Underlying Profit Guidance; Shares Fall 8% MT
Ryman Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Transcript : Ryman Healthcare Limited, H1 2024 Earnings Call, Nov 29, 2023
Ryman Healthcare Limited Provides Debt Facilities Update CI
Transcript : Ryman Healthcare Limited - Shareholder/Analyst Call
Ryman Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Transcript : Ryman Healthcare Limited, 2023 Earnings Call, May 19, 2023
New Zealand King Salmon Chairman Resigns MT
New Zealand shares end at 9-1/2-month high, Australia closed (Jan 26) RE
New Zealand shares inch lower in early trade, Australia closed RE
Ryman Healthcare Limited Announces Interim Dividend, Payable on December 16, 2022 CI
Transcript : Ryman Healthcare Limited, Q2 2023 Earnings Call, Nov 18, 2022
Ryman Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2022 CI
Australian shares hit over 2-week high as banks shine; all eyes on U.S. inflation data RE
Transcript : Ryman Healthcare Limited - Shareholder/Analyst Call
Ryman Healthcare Appoints Cheyne Chalmers as New Zealand CEO CI
UBS Adjusts Ryman Healthcare's Price Target to NZ$10.9 From NZ$10.5, Keeps at Neutral MT
Ryman Healthcare Limited Announces Final Dividend, Payable on June 17, 2022 CI
Chart Ryman Healthcare Limited
More charts
Ryman Healthcare Limited is a New Zealand-based company. The Company develops, owns and operates integrated retirement villages, rest homes, and hospitals for older people within New Zealand and Australia. It provides a range of retirement-living options, including apartments and townhouses and assisted living in serviced apartments. Its aged-care offering includes rest homes, hospitals and dementia care. The Company's assisted living offers a range of services, including scheduled transport services and outings, village management and administration, maintaining and operating the community amenities, and gardening and ground maintenance and others. Its one, two and three-bedroom apartments and townhouses offer a neutral color palette. It also offers musical entertainment, fashion shows, arts and crafts, and regular outings. It owns and operates approximately 40 villages across New Zealand and eight in Australia.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.12 NZD
Average target price
5.958 NZD
Spread / Average Target
+44.61%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RYM Stock
  4. News Ryman Healthcare Limited
  5. UBS Adjusts Ryman Healthcare's Price Target to NZ$10.9 From NZ$10.5, Keeps at Neutral